GO:0048392 intermediate mesodermal cell differentiation: Developmental Pathway, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0048392 describes the process by which a relatively unspecialized cell acquires the specialized features of an intermediate mesoderm cell.
• Intermediate mesoderm is the embryonic source of the urogenital system, including kidney, ureter, gonads and associated ducts.
• Directed differentiation of human pluripotent stem cells into intermediate mesoderm and kidney organoids has been achieved using defined growth factor cocktails.
• Key signaling pathways include BMP, FGF, retinoic acid and WNT, which pattern the intermediate mesoderm and its derivatives.
• Dysregulation of intermediate mesoderm differentiation is linked to renal and urogenital developmental disorders, and to endometriosis-associated ovarian neoplasia.
• CRISPR-based models (knockout, point mutation, knock-in, overexpression) enable causal dissection of genes controlling intermediate mesoderm specification.
Description
Intermediate mesodermal cell differentiation (GO:0048392) is the developmental process in which a relatively unspecialized cell acquires the specialized features of an intermediate mesoderm cell. The intermediate mesoderm is a transient embryonic tissue that gives rise to the urogenital system, including the kidney, ureter, gonads and their associated ducts. Understanding this process is fundamental for developmental biology and for regenerative medicine, as it provides the blueprint for generating kidney and urogenital tissues from pluripotent stem cells. Researchers study intermediate mesodermal cell differentiation to uncover the gene regulatory networks and signaling pathways that specify this lineage, and to model human nephrogenesis and urogenital diseases in vitro. The process is highly conserved across vertebrates and involves sequential inductive signals, transcription factor cascades, and morphogenetic movements. This article synthesizes authoritative QuickGO data and verified PubMed literature to provide a research-grade overview of GO:0048392, its molecular players, and the experimental methods used to investigate it.
intermediate mesodermal cell differentiation At A Glance
| GO ID | GO:0048392 |
|---|---|
| GO term | intermediate mesodermal cell differentiation |
| Ontology | biological_process |
| Synonym | intermediate mesoderm cell differentiation |
| Major function | Specification and maturation of intermediate mesoderm cells during embryogenesis |
| Related lineages | Kidney, ureter, gonads, and associated ducts |
| Key signaling pathways | BMP, FGF, retinoic acid, WNT |
| Research relevance | Kidney organoid generation, urogenital disease modeling, regenerative medicine |
What Is GO:0048392?
According to the Gene Ontology, intermediate mesodermal cell differentiation (GO:0048392) is the process in which a relatively unspecialized cell acquires specialized features of an intermediate mesoderm cell. This biological process encompasses the commitment, specification, and maturation of cells that constitute the intermediate mesoderm, a key embryonic germ layer derivative that forms between the paraxial and lateral plate mesoderm.
Why Is intermediate mesodermal cell differentiation Important in Cell Biology?
Intermediate mesodermal cell differentiation is critically important because it underpins the formation of the entire urogenital system, and its dysregulation leads to congenital kidney and urogenital anomalies. Moreover, the ability to recapitulate this process in vitro from human pluripotent stem cells has revolutionized disease modeling and drug screening for kidney diseases. Understanding the molecular mechanisms of intermediate mesoderm specification also provides insights into evolutionary developmental biology and offers potential therapeutic targets for regenerative nephrology.
• Forms the embryonic origin of the kidney, ureter, gonads, and associated ducts.
• Essential for understanding congenital anomalies of the kidney and urinary tract (CAKUT).
• Enables generation of kidney organoids from human iPS cells for disease modeling.
• Provides a platform for studying nephrogenesis and urogenital development in vitro.
• Involved in the pathogenesis of endometriosis-associated ovarian neoplasia.
• Key to regenerative medicine approaches for kidney replacement.
• Serves as a paradigm for mesodermal lineage specification and patterning.
• Facilitates drug discovery and toxicity screening for renal and urogenital disorders.
What Happens During intermediate mesodermal cell differentiation?
Induction and specification of intermediate mesoderm
In simple terms: In simple terms, early embryonic signals tell a group of cells to become intermediate mesoderm.
During gastrulation, cells in the posterior mesoderm receive inductive signals, including BMP, FGF, and WNT, that specify the intermediate mesoderm territory between the paraxial and lateral plate mesoderm. This specification involves the activation of transcription factors such as PAX2, PAX8, LHX1, and OSR1, which establish the intermediate mesoderm gene regulatory network. The process is highly dependent on the timing and concentration of these signals, as demonstrated in directed differentiation protocols from human pluripotent stem cells.
Formation of the nephric duct and pronephros
In simple terms: The intermediate mesoderm then forms a tube called the nephric duct, which is the precursor to the kidney and urinary ducts.
Following specification, intermediate mesoderm cells undergo morphogenetic movements to form the nephric duct, a transient epithelial structure that extends caudally. The nephric duct gives rise to the pronephros, the first and simplest kidney form, which is later replaced by the mesonephros and metanephros in higher vertebrates. Key genes involved in nephric duct formation include LHX1, PAX2, and GATA3, and their disruption leads to severe urogenital defects.
Mesenchymal-to-epithelial transition and metanephric mesenchyme
In simple terms: Some intermediate mesoderm cells change from a loose mesh into tightly packed epithelial structures that will form the kidney.
A critical step in intermediate mesoderm differentiation is the mesenchymal-to-epithelial transition (MET) that generates the metanephric mesenchyme, which subsequently undergoes branching morphogenesis to form nephrons. This process is regulated by WNT9B and WNT4 signaling from the ureteric bud, and involves the upregulation of epithelial markers such as E-cadherin. Human kidney organoids derived from iPS cells recapitulate this MET and subsequent nephrogenesis, providing a powerful model to study intermediate mesoderm differentiation.
Patterning along the anterior-posterior axis
In simple terms: The intermediate mesoderm is patterned along the body axis so that different regions form different organs.
Retinoic acid (RA) and FGF signaling gradients pattern the intermediate mesoderm along the anterior-posterior axis, determining the regional identity of urogenital derivatives. Anterior intermediate mesoderm gives rise to the pronephros and mesonephros, while posterior regions form the metanephros (definitive kidney). Manipulation of RA and FGF levels in differentiation protocols can direct human pluripotent stem cells toward specific urogenital lineages.
Differentiation into specialized urogenital cell types
In simple terms: Finally, intermediate mesoderm cells specialize into the many cell types of the kidney and reproductive system.
Intermediate mesoderm derivatives differentiate into diverse cell types, including nephron epithelial cells (podocytes, proximal tubule, distal tubule), collecting duct cells, and gonadal somatic cells. This terminal differentiation is driven by lineage-specific transcription factors such as WT1, SIX2, and FOXD1 for nephron progenitors, and SF1 for gonadal cells. Single-cell RNA sequencing of kidney organoids has revealed that these differentiation trajectories closely mirror human fetal development.
Key Genes Involved in GO:0048392 intermediate mesodermal cell differentiation
The following genes are central to intermediate mesodermal cell differentiation, as evidenced by their expression patterns, functional studies, and roles in urogenital development.
| Gene | Major Role | Research Relevance |
|---|---|---|
| PAX2 | Transcription factor essential for nephric duct and kidney development | Knockout models show renal agenesis; used in organoid differentiation |
| PAX8 | Regulates nephric duct formation and thyroid development | Marker of intermediate mesoderm; studied in kidney organoids |
| LHX1 | Lim homeobox transcription factor required for nephric duct and kidney | Knockout leads to urogenital defects; target for differentiation protocols |
| OSR1 | Odd-skipped related transcription factor in intermediate mesoderm | Regulates metanephric mesenchyme; studied in kidney organoids |
| WT1 | Wilms tumor suppressor; essential for metanephric mesenchyme | Mutations cause nephrotic syndrome; key marker in organoids |
| SIX2 | Maintains nephron progenitor pool | Critical for nephron formation; studied in organoid differentiation |
| FOXD1 | Specifies stromal progenitors in the kidney | Lineage tracing and knockout studies |
| GATA3 | Required for nephric duct and ureteric bud development | Mutations linked to urogenital anomalies |
| WNT9B | Secreted signal from ureteric bud inducing MET | Used in differentiation media; knockout blocks nephrogenesis |
| WNT4 | Regulates MET and female gonadal development | Knockout causes kidney and reproductive defects |
| BMP4 | Induces intermediate mesoderm and ureteric bud branching | Used in directed differentiation protocols |
| FGF9 | Promotes metanephric mesenchyme survival and proliferation | Added to kidney organoid cultures |
| RET | Receptor tyrosine kinase for GDNF signaling in ureteric bud | Mutations cause renal agenesis; target in organoids |
| GDNF | Ligand for RET; essential for ureteric bud outgrowth | Used in differentiation media for ureteric bud organoids |
| SALL1 | Transcription factor in metanephric mesenchyme | Mutations cause Townes-Brocks syndrome |
| EYA1 | Transcriptional coactivator in nephric duct | Mutations cause branchio-oto-renal syndrome |
| SIX1 | Coactivator with EYA1 in kidney development | Knockout leads to renal defects |
| HNF1B | Transcription factor in kidney and pancreas | Mutations cause renal cysts and diabetes syndrome |
How Is intermediate mesodermal cell differentiation Regulated?
Intermediate mesodermal cell differentiation is regulated by a complex interplay of signaling pathways, including BMP, FGF, WNT, and retinoic acid, which act in a temporally and spatially coordinated manner. Transcription factors such as PAX2, PAX8, LHX1, and OSR1 form a core regulatory network that reinforces intermediate mesoderm identity and represses alternative fates. Epigenetic modifiers, including chromatin remodelers, also influence the accessibility of key lineage-specific genes during differentiation. In directed differentiation protocols, the precise modulation of these pathways using small molecules and growth factors is essential to efficiently generate intermediate mesoderm and its derivatives from human pluripotent stem cells.
intermediate mesodermal cell differentiation and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| PAX2 | CAKUT, renal coloboma syndrome | Knockout iPSC-derived kidney organoids |
| RET | Hirschsprung disease, renal agenesis | Point mutation knock-in in HEK293 or iPSCs |
| WT1 | Wilms tumor, nephrotic syndrome | Knockout and knock-in in kidney organoids |
| HNF1B | Renal cysts and diabetes syndrome | Overexpression and knockout in iPSC-derived tubuloids |
| SALL1 | Townes-Brocks syndrome | CRISPR knockout in human pluripotent stem cells |
Congenital anomalies of the kidney and urinary tract (CAKUT)
Disruption of intermediate mesodermal cell differentiation leads to a spectrum of congenital anomalies of the kidney and urinary tract (CAKUT), including renal agenesis, hypoplasia, and duplex systems. Mutations in genes such as PAX2, LHX1, and RET have been identified in patients with CAKUT, underscoring the clinical relevance of this developmental process. Kidney organoids derived from patient iPSCs can model these anomalies and provide a platform for drug testing.
Endometriosis-associated ovarian neoplasia
Intermediate mesoderm-derived tissues, particularly the gonads and Müllerian ducts, are implicated in endometriosis-associated ovarian neoplasia. Aberrant differentiation of intermediate mesoderm derivatives may contribute to the pathogenesis of endometrioid and clear cell ovarian carcinomas arising from endometriosis. Studying intermediate mesoderm differentiation can therefore provide insights into the developmental origins of these tumors.
Wilms tumor and nephroblastoma
Wilms tumor, a pediatric kidney cancer, is thought to arise from aberrant persistence of nephron progenitor cells that fail to undergo proper differentiation. Mutations in WT1, SIX2, and other intermediate mesoderm genes are associated with Wilms tumor, highlighting the link between disrupted differentiation and oncogenesis. Kidney organoids and CRISPR models are valuable for dissecting these mechanisms.
From intermediate mesodermal cell differentiation-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Is PAX2 required for intermediate mesoderm specification? | PAX2 knockout human iPSCs differentiated to intermediate mesoderm |
| Does a specific RET point mutation cause renal agenesis? | RET point mutation knock-in in iPSCs followed by kidney organoid differentiation |
| Can overexpression of SIX2 expand nephron progenitors? | SIX2 overexpression in kidney organoids |
| What is the role of WT1 in podocyte differentiation? | WT1 knockout and tagged knock-in in iPSC-derived podocytes |
| How does HNF1B mutation affect tubule formation? | HNF1B knockout in human kidney organoids |
| Can CRISPR activation of OSR1 enhance intermediate mesoderm induction? | CRISPRa overexpression in pluripotent stem cells |
How to Study the intermediate mesodermal cell differentiation Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Directed differentiation | Efficiency of intermediate mesoderm induction | Generating kidney organoids from iPSCs |
| scRNA-seq | Transcriptional profiles of individual cells | Mapping differentiation trajectories |
| CRISPR knockout screening | Gene essentiality for differentiation | Identifying novel regulators |
| Immunofluorescence | Protein expression and localization | Validating marker expression in organoids |
| Flow cytometry | Quantification of surface markers | Sorting intermediate mesoderm cells |
| Western blot | Protein levels and modifications | Assessing signaling pathway activation |
| Organoid culture | 3D tissue architecture and function | Modeling nephrogenesis and disease |
| Lineage tracing | Cell fate and migration | Tracking intermediate mesoderm derivatives in vivo |
Directed differentiation and kidney organoid protocols
Directed differentiation of human pluripotent stem cells into intermediate mesoderm and kidney organoids is a cornerstone method for studying GO:0048392. These protocols use sequential treatment with growth factors such as BMP4, FGF9, and retinoic acid to mimic embryonic signaling, followed by three-dimensional culture to form organoids. The resulting organoids contain multiple lineages, including nephrons, stroma, and vasculature, and model human nephrogenesis.
Single-cell RNA sequencing
Single-cell RNA sequencing (scRNA-seq) of differentiating cultures and organoids has revealed the transcriptional trajectories of intermediate mesoderm cells and their derivatives. This method identifies cell types, lineage relationships, and novel marker genes, providing a high-resolution map of intermediate mesoderm differentiation.
CRISPR screening and functional genomics
CRISPR-based loss-of-function screens in human pluripotent stem cells undergoing intermediate mesoderm differentiation can identify genes essential for this process. Pooled screens with single-guide RNA libraries coupled to sequencing enable unbiased discovery of regulators, while arrayed screens allow detailed validation.
Imaging and lineage tracing
Live imaging and lineage tracing in model organisms (e.g., zebrafish, mouse) and in vitro organoids visualize the morphogenetic movements and cell fate decisions during intermediate mesoderm differentiation. Fluorescent reporters for key genes such as PAX2 or LHX1 enable real-time monitoring of differentiation.
How CRISPR Can Be Used to Study GO:0048392 intermediate mesodermal cell differentiation
Knockout
CRISPR knockout of candidate genes in human pluripotent stem cells followed by directed differentiation to intermediate mesoderm can reveal whether the gene is required for this process. For example, knockout of PAX2 or LHX1 results in failure to form intermediate mesoderm derivatives, validating their essential roles.
Point Mutation
Introducing disease-associated point mutations (e.g., in RET or HNF1B) using CRISPR base editing or homology-directed repair allows modeling of congenital urogenital anomalies in vitro. These models can be differentiated into kidney organoids to study the functional impact of the mutation.
Knock-in
Knock-in of fluorescent reporters (e.g., PAX2-GFP) or epitope tags enables live tracking of intermediate mesoderm cells and purification of specific populations. Tagged knock-in of transcription factors also facilitates chromatin immunoprecipitation to map binding sites during differentiation.
Overexpression
CRISPR activation (CRISPRa) or lentiviral overexpression of key transcription factors such as SIX2 or OSR1 can enhance or prolong intermediate mesoderm differentiation, providing insights into sufficiency and dosage effects. Overexpression models are also useful for generating large quantities of desired cell types for downstream applications.
How EDITGENE Supports intermediate mesodermal cell differentiation Research
Researchers studying intermediate mesodermal cell differentiation-related genes often need to determine whether a candidate gene is causally involved in lineage specification, whether a specific patient mutation alters protein function, or whether overexpression can drive desired cell fates. EDITGENE provides a comprehensive suite of CRISPR services to address these questions with precision and scale.
Contact EDITGENE today to design your custom CRISPR model for intermediate mesodermal cell differentiation research.
Frequently Asked Questions About intermediate mesodermal cell differentiation
What is intermediate mesodermal cell differentiation?
It is the developmental process (GO:0048392) in which unspecialized cells acquire the specialized features of intermediate mesoderm cells, the embryonic source of the urogenital system.
What genes are involved in intermediate mesodermal cell differentiation?
Key genes include PAX2, PAX8, LHX1, OSR1, WT1, SIX2, GATA3, WNT9B, WNT4, BMP4, FGF9, RET, GDNF, SALL1, EYA1, SIX1, and HNF1B.
How is intermediate mesoderm differentiation studied in the lab?
Researchers use directed differentiation of human pluripotent stem cells into kidney organoids, scRNA-seq, CRISPR screens, and imaging.
What diseases are linked to defects in intermediate mesoderm differentiation?
Congenital anomalies of the kidney and urinary tract (CAKUT), Wilms tumor, and endometriosis-associated ovarian neoplasia.
Can CRISPR be used to study intermediate mesoderm differentiation?
Yes, CRISPR knockout, point mutation, knock-in, and overexpression models in stem cells and organoids enable causal gene studies.
What signaling pathways regulate intermediate mesoderm differentiation?
BMP, FGF, WNT, and retinoic acid signaling pathways are central regulators.
What are kidney organoids and how are they related to intermediate mesoderm?
Kidney organoids are 3D structures derived from pluripotent stem cells that recapitulate intermediate mesoderm differentiation and nephrogenesis.
Which transcription factors are markers of intermediate mesoderm?
PAX2, PAX8, LHX1, and OSR1 are early markers of intermediate mesoderm.
How does EDITGENE support intermediate mesoderm research?
EDITGENE provides CRISPR knockout, point mutation, knock-in, overexpression, library screening, and bioinformatics services tailored to urogenital development.
What is the role of WT1 in intermediate mesoderm differentiation?
WT1 is essential for metanephric mesenchyme formation and podocyte differentiation; mutations cause Wilms tumor and nephrotic syndrome.
Conclusion
Intermediate mesodermal cell differentiation (GO:0048392) is a fundamental developmental process that gives rise to the urogenital system, and its study has profound implications for regenerative medicine and disease modeling. Advances in directed differentiation and CRISPR technologies have enabled researchers to dissect the gene regulatory networks and signaling pathways controlling this process with unprecedented precision. Continued research will illuminate the mechanisms of urogenital development and provide new therapeutic avenues for congenital and acquired kidney disorders.
References
- 3. Takasato M et al.. 2015. Kidney organoids from human iPS cells contain multiple lineages and model human nephrogenesis.. Nature 526(7574):564-8 PMID: 26444236
- 4. Shi M et al.. 2023. Directed differentiation of ureteric bud and collecting duct organoids from human pluripotent stem cells.. Nat Protoc 18(8):2485-2508 PMID: 37460630
- 5. Takasato M et al.. 2016. Generation of kidney organoids from human pluripotent stem cells.. Nat Protoc 11(9):1681-92 PMID: 27560173
- 6. Matias-Guiu X et al.. 2018. Endometriosis-associated ovarian neoplasia.. Pathology 50(2):190-204 PMID: 29241974
- 8. Hota SK et al.. 2022. Brahma safeguards canalization of cardiac mesoderm differentiation.. Nature 602(7895):129-134 PMID: 35082446
